frozen shoulder
Conditions
Interventions
research group:Lloxoprofen Sodium Gel Patch
control group:Flurbiprofen Gel Patch
Sponsors
Hunan Provincial People's Hospital
Eligibility
Sex/Gender
Male
Age
30 Years to 70 Years
Inclusion criteria
Inclusion criteria: 1. Patients diagnosed with frozen shoulder; 2. Meet the pain stage in the staging standard of frozen shoulder; 3. Those who did not take other related treatment drugs (such as oral diclofenac sodium sustained-release tablets, loxoprofen sodium tablets, etc.) within 4 weeks before screening and did not receive other treatment methods; 4. Aged 30-70 years (including 30 years old and 70 years old), gender is not limited; 5. Subjects voluntarily agreed to participate in this study and signed a written informed consent.
Exclusion criteria
Exclusion criteria: 1. Patients who have received relevant treatment in the past, or there may be effect indicators that may affect this study; 2. Patients with acute soft tissue injury of shoulder, infectious inflammation, fracture, dislocation, rheumatoid arthritis, etc.; 3. Patients with serious primary diseases such as diabetes, tumors, cardiovascular and cerebrovascular diseases, blood diseases, and mental illnesses; 4. Radiating shoulder pain or movement disorder not caused by frozen shoulder (such as cervical spondylosis, rotator cuff injury, subacromial impingement, lung cancer, cholecystitis, angina pectoris, myocardial infarction, etc.); 5. Those who have a history of allergies to the drugs in this study in the past; 6. Other situations that the investigator considers unsuitable to participate in this trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Effectiveness of treatment; | — |
Secondary
| Measure | Time frame |
|---|---|
| Visual Analogue Scale score;Cooper myelopathy score;Application comfort score;The incidence of adverse reactions; | — |
Countries
China
Contacts
Public ContactWang Jing
Hunan Provincial People's Hospital
Outcome results
None listed